Brett Matthew Hall Immuneering Corp (IMRX) insider trading activity

Brett Matthew Hall is CHIEF SCIENTIFIC OFFICER of Immuneering Corp. Currently has a direct ownership of 359,318 shares of IMRX, which is worth approximately $1.24 Million. The most recent transaction as insider was on Jun 23, 2025, when has been sold 6,007 shares (Class A Common Stock) at a price of $2.43 per share, resulting in proceeds of $14,597. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 359K

3.88% 3M change

3.88% 12M change

Total Value Held $1.24 Million

Brett Matthew Hall Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 23 2025	BUY Open market or private purchase	$14,597 $2.43 p/Share	6,007 Added 1.64%	359,318 Class A Common Stock
Jun 20 2025	BUY Open market or private purchase	$20,020 $2.7 p/Share	7,415 Added 2.06%	353,311 Class A Common Stock
Mar 20 2024	BUY Open market or private purchase	$20,020 $2.86 p/Share	7,000 Added 1.98%	345,896 Class A Common Stock
Mar 15 2024	BUY Grant, award, or other acquisition	$10,061 $1.62 p/Share	6,211 Added 1.8%	338,896 Class A Common Stock
May 25 2022	BUY Open market or private purchase	$10,000 $3.92 p/Share	2,551 Added 0.76%	332,685 Class A Common Stock
Mar 23 2022	BUY Open market or private purchase	$8,305 $7.91 p/Share	1,050 Added 0.32%	330,134 Class A Common Stock
Dec 22 2021	BUY Grant, award, or other acquisition	-	322,691 Added 49.51%	329,084 Class A Common Stock
Aug 03 2021	BUY Open market or private purchase	$20,295 $15.0 p/Share	1,353 Added 17.47%	6,393 Class A Common Stock
Aug 03 2021	BUY Conversion of derivative security	-	5,040 Added 50.0%	5,040 Class A Common Stock

BMH

Brett Matthew Hall

CHIEF SCIENTIFIC OFFICER

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IMRX shares.

Notify only if

Value

Insider Trading

Get notified when an Immuneering Corp insider buys or sells IMRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Immuneering Corp

Track Activities on IMRX

Account